The 3 analysts offering 12-month price forecasts for Aptevo Therapeutics Inc have a median target of 64.00, with a high estimate of 69.00 and a low estimate of 50.00. The median estimate represents a +178.75% increase from the last price of 22.96.
The current consensus among 3 polled investment analysts is to Buy stock in Aptevo Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$2.00
Reporting Date Aug 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.